Trial Profile
Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Lamivudine (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 12 Nov 2015 New trial record